Wednesday 6 March 2019

Reuters Health Report: Alnylam's gene-silencing drug meets main goal in late-stage study

Reuters.com Newsletter

Alnylam's gene-silencing drug meets main goal in late-stage study

Alnylam Pharmaceuticals Inc said on Wednesday its gene-silencing drug for treating a rare, painful disease met the main goal in a late-stage trial.

U.S. FDA chief tough on e-cigarettes steps down abruptly

U.S. Food and Drug Administration Commissioner Scott Gottlieb said on Tuesday that he plans to step down next month, a sudden resignation that calls into question how the agency will handle issues such as surging e-cigarette use among teens and efforts to increase competition in prescription drugs.

London HIV patient becomes world's second AIDS cure hope

An HIV-positive man in Britain has become the second known adult worldwide to be cleared of the AIDS virus after he received a bone marrow transplant from an HIV-resistant donor, his doctors said.

J&J nasal spray gets U.S. approval as first new type of anti-depressant in decades

The U.S. Food and Drug Administration on Tuesday said it approved a Johnson & Johnson nasal spray antidepressant for people resistant to other treatments but placed restrictions on use of the drug, which it warned could be misused and abused.

FDA finds asbestos in three Claire's cosmetics products

The U.S. Food and Drug Administration called on Congress to modernize rules for cosmetics safety on Tuesday after it issued an alert warning consumers not to use three cosmetics products sold by Claire's Stores Inc because they tested positive for asbestos, a known carcinogen.

U.S. AIDS activists welcome London 'cure' but warn against complacency

U.S. AIDS activists said on Tuesday they were encouraged by news that a patient in London became the second known person to be cleared of the deadly HIV infection but warned that the development is only one more step in a decades-long battle.

Hands-off parenting tied to higher risk of teen gun use

(Reuters Health) - When parents of boys don't enjoy parenthood or don't spend a lot of time playing or talking with them, their sons may be more likely to use guns in adolescence, a U.S. study suggests.

Female scientists get smaller first-time grants than men

(Reuters Health) - Women in science receive smaller research grants than men even when they have similar qualifications, a U.S. study suggests.

Spending on abstinence-only education not tied to fewer teen births

(Reuters Health) - U.S. government spending on abstinence-only education doesn't appear to reduce teen pregnancies and in some areas is having the opposite effect, a recent study suggests.

MSF-run hospital develops 3D printed prosthetics for war victims

A hospital in Jordan has given a victim of Yemen's war new hope for the future, thanks to the cutting edge technology of 3D printed prosthetics. 

French court dismisses damages claims against Merck over thyroid drug

A court in the French city of Lyon threw out on Tuesday claims made by 4,113 plaintiffs for damages against Merck over changes to its thyroid drug Levothyrox.

Related Videos

Pope to open secret WW2 archive for Jewish groups

R. Kelly released from jail after posting bail

Introducing the all-new
Reuters News app

The new Reuters News app is here, redesigned from the ground up to fit your busy life.

Get it now on iOS